Receive The Newest Study Notifications

Anavex Life Sciences Announces Achievement of Enrollment Target for the ANAVEX®2-73 (blarcamesine) Phase 2 Parkinson’s Disease Dementia (PDD) Clinical Trial

by Lance Smith | Jan 27, 2020 | Study Scavenger Clinical Trial Recruitment Platform

NEW YORK, Jan. 27, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...

AVEO Oncology and Biodesix Announce Results from Phase 1b Study of Ficlatuzumab, Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

by Lance Smith | Jan 27, 2020 | Study Scavenger Clinical Trial Recruitment Platform

– Data Presented at the 2020 ASCO GI Cancers Symposium – CAMBRIDGE, Mass. & BOULDER, Colo.–(BUSINESS WIRE)–AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced the presentation of results from an investigator-sponsored Phase 1b...

Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy

by Lance Smith | Jan 24, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy  – Study meets primary endpoint in patients living with type 1 SMA – – To date, more than 400 patients have...

Tonix Pharmaceuticals to Present Results from Preclinical Study of TNX-801 in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference

by Lance Smith | Jan 24, 2020 | Study Scavenger Clinical Trial Recruitment Platform

NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals, Inc. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it will be presenting preclinical results of TNX-801 in a poster at the 2020 ASM...

Exelixis Announces Results for Combination of Cabozantinib and Nivolumab With or Without Ipilimumab in Advanced Hepatocellular Carcinoma

by Lance Smith | Jan 24, 2020 | Study Scavenger Clinical Trial Recruitment Platform

– Data from the CheckMate 040 trial presented at the 2020 American Society of Clinical Oncology’s Gastrointestinal Cancers Symposium – January 24, 2020 07:30 AM Eastern Standard Time ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (NASDAQ: EXEL) today...

Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody

by Lance Smith | Jan 23, 2020 | Study Scavenger Clinical Trial Recruitment Platform

HANGZHOU and SHAOXING, China, Jan. 22, 2020 /PRNewswire/ — Ascletis Pharma Inc. (Ascletis, 1672.HK) announces today the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from China’s National Medical Products...